These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3088755

  • 41. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
    Liu JN, Gurewich V.
    Biochemistry; 1992 Jul 14; 31(27):6311-7. PubMed ID: 1385727
    [Abstract] [Full Text] [Related]

  • 42. Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitro.
    Runge MS, Bode C, Matsueda GR, Haber E.
    Biochemistry; 1988 Feb 23; 27(4):1153-7. PubMed ID: 3130094
    [Abstract] [Full Text] [Related]

  • 43. Thrombolytic agents.
    Collen D, Lijnen HR.
    Thromb Haemost; 2005 Apr 23; 93(4):627-30. PubMed ID: 15841305
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Stachybotrydial selectively enhances fibrin binding and activation of Glu-plasminogen.
    Sasaoka M, Wada Y, Hasumi K.
    J Antibiot (Tokyo); 2007 Nov 23; 60(11):674-81. PubMed ID: 18057696
    [Abstract] [Full Text] [Related]

  • 46. Kinetic analyses of the activation of Glu-plasminogen by urokinase in the presence of fibrin, fibrinogen or its degradation products.
    Watahiki Y, Takada Y, Takada A.
    Thromb Res; 1987 Apr 01; 46(1):9-18. PubMed ID: 3590117
    [Abstract] [Full Text] [Related]

  • 47. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM, Greco WR.
    Cancer Res; 1986 Apr 01; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [Abstract] [Full Text] [Related]

  • 48. [New thrombolytic agents].
    Nguyen G, Samama M.
    Ann Biol Clin (Paris); 1987 Apr 01; 45(2):212-8. PubMed ID: 3113300
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
    Korner G, Bjornsson TD, Vlodavsky I.
    J Cell Physiol; 1993 Mar 01; 154(3):456-65. PubMed ID: 8436596
    [Abstract] [Full Text] [Related]

  • 53. Kringle 1 domain of human tissue-type plasminogen activator is a functional module mediating fibrinogen-stimulated plasminogenolytic activity.
    Stern A, Weidle UH.
    Gene; 1990 Mar 15; 87(2):305-8. PubMed ID: 2158930
    [Abstract] [Full Text] [Related]

  • 54. A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system.
    Yarzábal A, Avilán L, Hoelzl K, de Muñoz M, Puig J, Kansau I.
    Braz J Med Biol Res; 2000 Sep 15; 33(9):1015-21. PubMed ID: 10973131
    [Abstract] [Full Text] [Related]

  • 55. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots.
    Neuss S, Schneider RK, Tietze L, Knüchel R, Jahnen-Dechent W.
    Cells Tissues Organs; 2010 Sep 15; 191(1):36-46. PubMed ID: 19390164
    [Abstract] [Full Text] [Related]

  • 56. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
    Shenkman B, Livnat T, Budnik I, Tamarin I, Einav Y, Martinowitz U.
    Blood Coagul Fibrinolysis; 2012 Dec 15; 23(8):729-33. PubMed ID: 22918041
    [Abstract] [Full Text] [Related]

  • 57. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis.
    Kitching AR, Holdsworth SR, Ploplis VA, Plow EF, Collen D, Carmeliet P, Tipping PG.
    J Exp Med; 1997 Mar 03; 185(5):963-8. PubMed ID: 9120402
    [Abstract] [Full Text] [Related]

  • 58. Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins.
    de Vries C, Veerman H, Blasi F, Pannekoek H.
    Biochemistry; 1988 Apr 05; 27(7):2565-72. PubMed ID: 3132969
    [Abstract] [Full Text] [Related]

  • 59. Expression of fibrinolytic antigens in redistributed cardiac mast cells in auricular thrombosis.
    Bankl HC, Radaszkiewicz T, Pikula B, Baghestanian M, Mehrabi MR, Bankl H, Lechner K, Valent P.
    Hum Pathol; 1997 Nov 05; 28(11):1283-90. PubMed ID: 9385934
    [Abstract] [Full Text] [Related]

  • 60. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
    Husain SS.
    Biochemistry; 1991 Jun 11; 30(23):5797-805. PubMed ID: 1828371
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.